Doc Group Deals Take Health Care in New Directions

Doc Group Deals Take Health Care in New Directions

With more than 180 deals announced so far in 2019, the Physician Medical Group sector is roaring toward another strong close. The usual specialties—dental, dermatology and ophthalmology—are still very active, but after 10 to 20 years of consolidation, their trajectories are flattening. Other specialties are gaining traction with private equity investors, particularly orthopedics, gastrointestinal (GI), urology, pain management and women’s health. Even ear, nose & throat (ENT) deals are picking up. We spoke with a few deal makers to find out where this sector stands at the end of 2019 and what’s ahead for M&A in 2020. The hot areas this year have been surgical subspecialties,... Read More »
Warburg Pincus Creates Mega-Care Model in NYC Metro Area

Warburg Pincus Creates Mega-Care Model in NYC Metro Area

It takes a big platform to combine a prominent urgent care company with a major multi-specialty practice. Warburg Pincus is now providing that platform. On June 21, the private equity firm announced its urgent care company, New York City-based CityMD, will merge with Summit Medical Group, a physician-owned multispecialty medical practice anchored in Berkeley Heights, New Jersey. The combined organization aims to deliver high-quality medical care, which is the stated goal of every decent healthcare provider. The key component is convenience, delivered via its network of physicians and care locations from New Jersey to Long Island, New York. CityMD was founded in 2010 by Dr. Richard Park and... Read More »
Cardinal Health Sheds its China Operations

Cardinal Health Sheds its China Operations

Cardinal Health Inc. (NYSE: CAH) put its Cardinal Health China business up for sale in July of this year, following concerns that upcoming drug distribution reform could threaten the company’s growth. Cardinal’s China business is the eighth largest drug distributor in the country, operating 14 direct sales units and 17 distribution centers that cover 322 cities and 11,000 medical institutions. The bidding process was very competitive, according to Reuters, and names like Warburg Pincus were rumored to have competed in the final rounds, among other private equity and Chinese pharmaceutical bidders. On November 14th, Cardinal Health announced that Shanghai Pharmaceuticals Holding Co., Ltd.... Read More »
Telehealth Deals Dial Up in Early 2017

Telehealth Deals Dial Up in Early 2017

Three telehealth deals have been announced in the first six weeks of 2017, an indication that this sub-sector of digital health is on track to set a(nother) M&A record. In 2016, eight of these deals were announced, an increase of 100% compared with 2014 and 60% versus 2015. Telehealth is loosely defined as the use of technology to support long-distance clinical healthcare. Some examples include live video between a patient and healthcare provider, transmission of medical images to a specialist, and remote monitoring which allows patients and providers to track vitals and manage chronic conditions. On February 2nd, 2017, Specialists On Call, Inc., a portfolio company of Warburg Pincus... Read More »
Werfen Life Divests to Focus on the Hemostasis Market

Werfen Life Divests to Focus on the Hemostasis Market

The growing prevalence of autoimmune and blood disorders has put a spotlight on the science of hemostasis, the process of stopping bleeding and keeping blood within the damaged blood vessel. The coagulation/hemostasis analyzer market is expected to reach $4.84 billion by 2021, according to a report from MarketsandMarkets. Among the products, clinical laboratory analyzers are expected to account for the largest share of the market. Some big name players are already strengthening their hemostasis portfolios. In December 2015, Mallinckrodt plc (NYSE: MNK) purchased a global portfolio of three hemostasis products from The Medicines Company (NASDAQ: MDCO) for an upfront payment of $175 million,... Read More »